Back to top
Read MoreHide Full Article

FUJIFILM Holdings Corporation (FUJIY - Free Report) continues to boost its organic growth trajectory on the back of a number of new imaging solutions contract wins.

Over the last month, Fujifilm’s shares yielded a return of 3.6%, as against the loss of 25% incurred by the industry.

FUJIFILM Medical Systems U.S.A., Inc. (FUJIFILM Medical Systems) recently secured seven enterprise imaging solutions contracts from healthcare providers like Greater Hudson Valley Health System, Hackensack Meridian Health, Halifax Health, Valley Medical Center, West Virginia University Health System, Elliot Hospital and Capital Health.

Receipt of such lucrative contracts proves that FUJIFILM Medical Systems is currently recognized as a major enterprise imaging partner across the nation. The company owns a wide range of Synapse Enterprise Imaging portfolio of non-imitable technologies which outspread the conventional cardiology and radiology imaging areas.

Per the above-mentioned deals, FUJIFILM Medical Systems will supply various products such as Synapse VNA, Synapse Cardiovascular, Synapse Mobility Enterprise Viewer, Synapse Cloud Services and Synapse 5 PACS to the healthcare providers.

Our Take

Fujifilm currency carries a Zacks Rank #4 (Sell). We believe that headwinds such as further appreciation of the Japanese Yen, depreciation of Asian currencies, stronger industry specific rivalry and the Brexit-induced uncertain macroeconomic environment in Europe will likely make matters worse for the company, moving ahead.

However, amid all headwinds, Fujifilm is poised to grow on the back of such above discussed business contracts. Furthermore, near-term profitability is anticipated to improve on the back of the three major pillars – efficient management, expansion of international operations and launch of businesses.

Stocks to Consider

A few better-ranked stocks in the same space are listed below:

Applied Optoelectronics, Inc. (AAOI - Free Report) delivered an average positive earnings surprise of 17.98% for the last four quarters and currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

ACI Worldwide, Inc. (ACIW - Free Report) presently carries a Zacks Rank #2 (Buy) and generated an average positive earnings surprise of 31.25% over the trailing four quarters.

Axcelis Technologies, Inc. (ACLS - Free Report) , which also carries a Zacks Rank #2, pulled off an average positive earnings surprise of 35.04% over the past four quarters.

4 Surprising Tech Stocks to Keep an Eye on

Tech stocks have been a major force behind the market’s record highs, but picking the best ones to buy can be tough. There’s a simple way to invest in the success of the entire sector. Zacks has just released a Special Report revealing one thing tech companies literally cannot function without. More importantly, it reveals 4 top stocks set to skyrocket on increasing demand for these devices. I encourage you to get the report now – before the next wave of innovations really takes off.

See Stocks Now>>



More from Zacks Analyst Blog

You May Like